May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
The Use of Subconjunctival Mitomycin C Preoperatively for Management of Pterygium
Author Affiliations & Notes
  • L. Thompson
    Ophthalmology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL
  • M. Adenwalla
    Ophthalmology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL
  • J.C. Whelchel
    Ophthalmology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL
  • A. Elbiaadi
    Ophthalmology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL
    Ophthalmology, FUHS/ The Chicago Medical School, North Chicago, IL
  • P.B. Dray
    Ophthalmology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL
    Ophthalmology, FUHS/ The Chicago Medical School, North Chicago, IL
  • R.M. Ahuja
    Ophthalmology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL
    Ophthalmology, FUHS/ The Chicago Medical School, North Chicago, IL
  • Footnotes
    Commercial Relationships  L. Thompson, None; M. Adenwalla, None; J.C. Whelchel, None; A. Elbiaadi, None; P.B. Dray, None; R.M. Ahuja, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 2937. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. Thompson, M. Adenwalla, J.C. Whelchel, A. Elbiaadi, P.B. Dray, R.M. Ahuja; The Use of Subconjunctival Mitomycin C Preoperatively for Management of Pterygium . Invest. Ophthalmol. Vis. Sci. 2004;45(13):2937.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To evaluate the efficacy and safety of using of 0.10 ml of 0.10 mg/ml mitomycin C as adjunctive therapy before pterygium surgery. Methods: A retrospective review of 30 eyes of 22 consecutive patients with no prior history of pterygium surgery treated with subconjunctival injection of 0.10 ml of 0.10 mg/ml mitomycin C one month prior to bare sclera pterygium excision. Our main outcome measures were recurrence of pterygium and patient satisfaction. Results:The pterygia resolved in 96% (29) of patients with an average follow up time of 2.2 months (range of 1.3 to 3.2 months). All but one patient expressed satisfaction with the postoperative results. Four (12%) patients suffered from transient post–injection blepharoconjunctivitis, and one patient complained of transient diplopia on extreme lateral gaze following excision at 2 months follow–up. Conclusions: Based on previous studies using higher doses of mitomycin C with successful outcomes, we conducted this study to determine whether a lower dose could prove equally effective but with lower adverse effects such as post–injection blepharoconjunctivitis in addition to other side effects. Based on a limited mean follow up time of 2.2 months, the lower dose of preoperatively injected subconjunctival mitomycin C is thus far effective in the treatment of pterygium with regards to recurrence and patient satisfaction. However, the adverse effect of blepharoconjunctivitis remains similar to prior studies.

Keywords: Pterygium • cornea: clinical science 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×